These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2650414

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis.
    Byrne JL, Stainer C, Hyde H, Miflin G, Haynes AP, Bessell EM, Russell NH.
    Bone Marrow Transplant; 1998 Sep; 22(6):541-5. PubMed ID: 9758340
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Use of cyclosporine for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
    Gluckman E, Devergie A, Lokiec F.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):461-9. PubMed ID: 3291282
    [No Abstract] [Full Text] [Related]

  • 49. Role of immunosuppressive drugs for prevention of graft-v-host disease after human HLA matched bone marrow transplantation.
    Gluckman E, Devergie A, Lokiec F, Traineau R, Cosset JM, Lemercier N, Varrin F, Cavazzana M, de Castro H, Meletis J.
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):61-5. PubMed ID: 3321648
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation--combination protocol of high dose methylprednisolone, prednisolone and methotrexate].
    Shinohara Y, Kai S, Misawa M, Fujimori Y, Okamoto T, Kohsaki M, Kanamaru A, Ifuku H, Ohe Y, Hara H.
    Rinsho Ketsueki; 1986 Jan; 27(1):30-5. PubMed ID: 3520045
    [No Abstract] [Full Text] [Related]

  • 52. Regeneration of genetically restricted immune functions after human bone marrow transplantation: influence of four different strategies for graft-v-host disease prophylaxis.
    Donnenberg AD, Hess AD, Duff SC, Bright EC, Noga SJ, Rowley SD, Saral R, Santos GW.
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):144-52. PubMed ID: 3321641
    [No Abstract] [Full Text] [Related]

  • 53. Graft versus host disease in children: the AIEOP BMT group experience.
    Porta F, Nespoli L, Uderzo C, Conter V, Miniero R, Arcese W, Dini G, Colleselli P, Bagnulo S, Andolina M.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():149-50. PubMed ID: 2627617
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Prevention and treatment of acute graft-versus-host disease.
    Neudorf S, Filipovich A, Ramsay N, Kersey J.
    Semin Hematol; 1984 Apr; 21(2):91-100. PubMed ID: 6377502
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Bone marrow transplantation in acute nonlymphoblastic leukemia.
    Zwaan FE, Jansen J.
    Semin Hematol; 1984 Jan; 21(1):36-42. PubMed ID: 6367055
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.